TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 19333174

Group type: EXPERIMENTAL
Intervention: Therapeutic massage
Number of subjects: 64

Group type: COMPARATOR
Intervention: Self-care book
Number of subjects: 64
Study: 16413347

Group type: EXPERIMENTAL
Intervention: Low-fat, vegan diet, exercise, and stress management
Number of subjects: 93

Group type: COMPARATOR
Intervention: Usual-care control
Number of subjects: 93
Study: 15243303

Group type: EXPERIMENTAL
Intervention: Rosiglitazone
Number of subjects: 48

Group type: COMPARATOR
Intervention: Glibenclamide
Number of subjects: 48
Study: 11510794

Group type: EXPERIMENTAL
Intervention: Noninvasive mechanical ventilation (NIMV)
Number of subjects: 720

Group type: COMPARATOR
Intervention: Conventional approach
Number of subjects: 720
Study: 8988885

Group type: EXPERIMENTAL
Intervention: Vaccine 1
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Vaccine 2
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Vaccine 3
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control (unimmunized)
Number of subjects: 46
Study: 8233271

Group type: EXPERIMENTAL
Intervention: 500-mg naproxen suppositories
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 3660461

Group type: EXPERIMENTAL
Intervention: BCG vaccination
Number of subjects: 136

Group type: COMPARATOR
Intervention: No BCG vaccination
Number of subjects: 136
Study: 30731451

Group type: EXPERIMENTAL
Intervention: AZD3342
Number of subjects: 90

Group type: COMPARATOR
Intervention: MTX
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: MTX + AZD3342
Number of subjects: 90
Study: 27126905

Group type: EXPERIMENTAL
Intervention: Mobile phone-based education (telephone-delivered educational session and phone/text access to a nurse for 30 days after delivery)
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: Mobile phone-based education
Number of subjects: 178

Group type: COMPARATOR
Intervention: Control group (no mobile phone-based education)
Number of subjects: 178
Study: 24796227

Group type: EXPERIMENTAL
Intervention: Coaching intervention (12-week, 6-session, phone-based)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Waitlisted control group
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Coaching intervention
Number of subjects: 59
Study: 22875143

Group type: EXPERIMENTAL
Intervention: Telemonitoring service for COPD patients
Number of subjects: 38
Study: 21034476

Group type: EXPERIMENTAL
Intervention: Goal-directed fluid therapy (GDT) with individualized fluid replacement
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: ScvO2 ≥ 71%
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: P(cv-a)CO2
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: ScvO2 ≥ 71% with P(cv-a)CO2
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: ROC curve analysis
Number of subjects: 70
Study: 18763691

Group type: EXPERIMENTAL
Intervention: 20 mg HPP-containing tablets
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: 7 mg HPP-containing tablets
Number of subjects: 28

Group type: COMPARATOR
Intervention: 0% HPP control tablets
Number of subjects: 28
Study: 17000362

Group type: EXPERIMENTAL
Intervention: Aortic valve replacement (AVR)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Doppler tissue imaging
Number of subjects: 34
Study: 14602747

Group type: EXPERIMENTAL
Intervention: Phytoestrogen (114 mg isoflavonoids)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 10951436

Group type: EXPERIMENTAL
Intervention: deflazacort (0.9 mg/kg/day)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: prednisone (0.75 mg/kg/day)
Number of subjects: 18

Group type: COMPARATOR
Intervention: untreated DMD patients (natural history control)
Number of subjects: 18
Study: 8797398

Group type: EXPERIMENTAL
Intervention: Fenoterol (200 micrograms per puff, max 16 puffs)
Number of subjects: 257

Group type: COMPARATOR
Intervention: Albuterol (100 micrograms per puff, max 16 puffs)
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Fenoterol (200 micrograms per puff)
Number of subjects: 257

Group type: COMPARATOR
Intervention: Albuterol (100 micrograms per puff)
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 257
Study: 1474082

Group type: EXPERIMENTAL
Intervention: Naloxone (0.4 mg/kg iv)
Number of subjects: 9
Study: 6706302

Group type: EXPERIMENTAL
Intervention: Dietary protein (80 gm per day)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Branched-chain enriched amino acid solution (BCAA, 80 gm per day)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Dietary protein
Number of subjects: 37

Group type: COMPARATOR
Intervention: Branched-chain enriched amino acid solution (BCAA)
Number of subjects: 37
Study: 31814710

Group type: EXPERIMENTAL
Intervention: Apatinib as maintenance therapy following chemotherapy
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Apatinib as palliative following chemotherapy
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Apatinib alone as salvage therapy
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Adverse effects of Apatinib
Number of subjects: 28
Study: 29691947

Group type: EXPERIMENTAL
Intervention: Family-based treatment (FBT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Adolescent focused therapy
Number of subjects: 0
Study: 27252412

Group type: EXPERIMENTAL
Intervention: 600 μg GTL001 + imiquimod
Number of subjects: 47

Group type: COMPARATOR
Intervention: 600 μg GTL001 + placebo cream
Number of subjects: 47

Group type: COMPARATOR
Intervention: placebo + imiquimod
Number of subjects: 47
Study: 25285696

Group type: EXPERIMENTAL
Intervention: Transversus abdominis plane block
Number of subjects: 79

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 79
Study: 22445475

Group type: EXPERIMENTAL
Intervention: Cockroft & Gault (C&G)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: 24 h creatinine clearance
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Modification of Diet in Renal Disease (MDRD-6)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Cystatin C-based estimation
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Modification of Diet in Renal Disease (MDRD-4)
Number of subjects: 19
Study: 18790588

Group type: EXPERIMENTAL
Intervention: In-house semi-nested PCR assay targeting the 16S rRNA gene of Eubacteria
Number of subjects: 112
Study: 17680515

Group type: EXPERIMENTAL
Intervention: Sequential SV‐CABG (seqSV‐CABG)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Single SV‐CABG (sSV‐CABG)
Number of subjects: 90
Study: 17169645

Group type: EXPERIMENTAL
Intervention: Periprostatic infiltration of 6 mL 1% lidocaine
Number of subjects: 120

Group type: COMPARATOR
Intervention: Periprostatic and apical infiltration: 4 mL 1% lidocaine at the prostate-seminal vesicle junction and 2 mL infiltration at the prostatic apex
Number of subjects: 120
Study: 12578924

Group type: EXPERIMENTAL
Intervention: Voice Treatment (VT) using the Lee Silverman Voice Treatment method
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Voice Treatment (VT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Healthy control group (no treatment)
Number of subjects: 0

Group type: COMPARATOR
Intervention: VT-untreated patients
Number of subjects: 0
Study: 10578771

Group type: EXPERIMENTAL
Intervention: Peer counseling program
Number of subjects: 291

Group type: COMPARATOR
Intervention: No peer counseling
Number of subjects: 291
Study: 8711707

Group type: EXPERIMENTAL
Intervention: High dose chemotherapy with autologous stem cell support
Number of subjects: 90

Group type: COMPARATOR
Intervention: Conventional chemotherapy
Number of subjects: 90
Study: 1898434

Group type: EXPERIMENTAL
Intervention: Caffeine
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 6362729

Group type: EXPERIMENTAL
Intervention: Haloperidol
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 31776726

Group type: EXPERIMENTAL
Intervention: R-GEM-L (lenalidomide + rituximab + methylprednisolone + gemcitabine)
Number of subjects: 34

Group type: COMPARATOR
Intervention: R-GEM-P (rituximab + methylprednisolone + gemcitabine)
Number of subjects: 34
Study: 31531572

Group type: EXPERIMENTAL
Intervention: General anesthesia with bilateral superficial cervical plexus blockade (G2)
Number of subjects: 100

Group type: COMPARATOR
Intervention: General anesthesia alone (G1)
Number of subjects: 100
Study: 29040873

Group type: EXPERIMENTAL
Intervention: Immediate Intervention group (Drive Smart training)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Delayed Intervention group (documentary video followed by Drive Smart training)
Number of subjects: 25
Study: 27030499

Group type: EXPERIMENTAL
Intervention: medicated genefix IUD
Number of subjects: 840

Group type: EXPERIMENTAL
Intervention: medicated γ IUD
Number of subjects: 840

Group type: COMPARATOR
Intervention: control group (no IUD or steroids)
Number of subjects: 840
Study: 25289942

Group type: EXPERIMENTAL
Intervention: Tiotropium bromide (18 μg)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 126
Study: 21959560

Group type: EXPERIMENTAL
Intervention: Education about AV fistula care
Number of subjects: 32
Study: 18789646

Group type: EXPERIMENTAL
Intervention: High support during birth
Number of subjects: 137

Group type: COMPARATOR
Intervention: Low support during birth
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: High stressful events
Number of subjects: 137

Group type: COMPARATOR
Intervention: Low stressful events
Number of subjects: 137
Study: 17708098

Group type: EXPERIMENTAL
Intervention: Cyclophosphamide for remission induction in patients with generalized disease or Churg-Strauss syndrome with risk factors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Azathioprine for maintenance of remission
Number of subjects: 0
Study: 15611795

Group type: EXPERIMENTAL
Intervention: Sequential MTX (200 mg m(‐2) i.v. on days 1 and 15) followed by FU (600 mg m(‐2) i.v. on days 2 and 16) and LV rescue (15 mg p.o. q 6 h x 6 doses)
Number of subjects: 1945

Group type: COMPARATOR
Intervention: 5-fluorouracil (370 mg m(‐2) i.v. bolus) preceded by leucovorin (100 mg m(‐2) i.v. bolus on days 1-5)
Number of subjects: 1945
Study: 11587367

Group type: EXPERIMENTAL
Intervention: High-dose cytosine arabinoside
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Changes in anthracyclines
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Use of hematopoietic growth factors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stem cell transplantation in first remission
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Modulation of the multidrug resistance phenotype
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nonmyeloablative allogeneic stem cell transplantation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Refinements in autologous stem cell transplantation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Manipulations of neoangiogenesis in the bone marrow
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Incorporation of gemtuzumab zogamicin into treatment regimens
Number of subjects: 0
Study: 9144906

Group type: EXPERIMENTAL
Intervention: Tolterodine 2 mg b.i.d.
Number of subjects: 242

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 242
Study: 16358396

Group type: EXPERIMENTAL
Intervention: Obese subjects with binge eating disorder (BED) in multiple-item meal
Number of subjects: 0

Group type: COMPARATOR
Intervention: Obese subjects without binge eating disorder (BED) in multiple-item meal
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Normal-weight bulimic patients (BN) in multiple-item meal
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-obese controls in multiple-item meal
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Obese subjects with or without binge-eating disorder in single-item meal (ice cream)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-obese controls in single-item meal (ice cream)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Patients with bulimia nervosa (BN) in single-item meal (ice cream)
Number of subjects: 0
Study: 3537019

Group type: EXPERIMENTAL
Intervention: Scaling and root planing with modified Widman flap procedure
Number of subjects: 16

Group type: COMPARATOR
Intervention: Scaling and root planing alone (control)
Number of subjects: 16
Study: 29363261

Group type: EXPERIMENTAL
Intervention: 8-Prenylnaringenin (8-PN)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 6-Prenylnaringenin (6-PN)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 27056401

Group type: EXPERIMENTAL
Intervention: Radiotherapy
Number of subjects: 40
Study: 25544027

Group type: EXPERIMENTAL
Intervention: Enhanced REP (provider coaching; N=40 sites) for 6 months followed by Standard REP for 6 months
Number of subjects: 158

Group type: COMPARATOR
Intervention: Standard REP (N=49 sites) for 6 months followed by 6 months of Enhanced REP for sites still not responding
Number of subjects: 158
Study: 23628502

Group type: COMPARATOR
Intervention: Combined aerobic and resistance training (CTG, n=16)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Aerobic training (ATG, n=15)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (n=17)
Number of subjects: 48
Study: 21915003

Group type: EXPERIMENTAL
Intervention: 27-gauge SC button
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 24-gauge catheter
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 20-gauge catheter
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Double-chevron securement
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Transparent semipermeable membrane dressing (TSM)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Overall incidence of technical challenges (TCs)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Infusion-site reactions (pain, erythema, swelling)
Number of subjects: 100
Study: 18326598

Group type: EXPERIMENTAL
Intervention: Serum 25-hydroxyvitamin D [25(OH)D] concentrations
Number of subjects: 637

Group type: EXPERIMENTAL
Intervention: Sun exposure
Number of subjects: 637

Group type: EXPERIMENTAL
Intervention: BMI
Number of subjects: 637
Study: 17163239

Group type: EXPERIMENTAL
Intervention: Bendroflumethiazide 1.25 mg/day and potassium chloride
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Bendroflumethiazide 2.5 mg/day and potassium chloride
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Amlodipine 5 mg/day
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Enalapril 10 mg/day
Number of subjects: 312
Study: 14557093

Group type: EXPERIMENTAL
Intervention: Simulator exams (sim)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Oral objective-structured clinical examination (OSCE) sessions (oral)
Number of subjects: 23
Study: 10746824

Group type: EXPERIMENTAL
Intervention: Glipizide (11 mg/day)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Glyburide (10 mg/day)
Number of subjects: 18
Study: 9106905

Group type: EXPERIMENTAL
Intervention: m-CPP (0.08 mg/kg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: ondansetron (0.15 mg/kg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: ondansetron pretreatment with m-CPP
Number of subjects: 12

Group type: COMPARATOR
Intervention: m-CPP with ondansetron pretreatment
Number of subjects: 12
Study: 1390574

Group type: EXPERIMENTAL
Intervention: Ceramic bracket with chemical retention
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Ceramic bracket with mechanical retention
Number of subjects: 51

Group type: COMPARATOR
Intervention: Metal bracket with foil-mesh base
Number of subjects: 51
Study: 6460474

Group type: EXPERIMENTAL
Intervention: Acne treatment
Number of subjects: 331

Group type: EXPERIMENTAL
Intervention: Acne grading scales and papule counts
Number of subjects: 331

Group type: EXPERIMENTAL
Intervention: Comedo grading scale and comedo count
Number of subjects: 331

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 331
Study: 31984445

Group type: EXPERIMENTAL
Intervention: 125 mg D-cycloserine
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 30633081

Group type: EXPERIMENTAL
Intervention: Elbow position at 90 degrees
Number of subjects: 2

Group type: COMPARATOR
Intervention: Elbow position at 20 degrees
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Smaller fragment group (0.6 cm osteotomy)
Number of subjects: 2
Study: 28926288

Group type: EXPERIMENTAL
Intervention: Inpatient palliative care integrated with transplant care
Number of subjects: 160

Group type: COMPARATOR
Intervention: Transplant care alone
Number of subjects: 160
Study: 25666504

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (50,000 IU/week for 6 months)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no supplementation)
Number of subjects: 40
Study: 25388499

Group type: EXPERIMENTAL
Intervention: Healthcare worker training
Number of subjects: 715
Study: 21911655

Group type: EXPERIMENTAL
Intervention: 20 IU of insulin
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: 40 IU of insulin
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study: 19444555

Group type: EXPERIMENTAL
Intervention: Landiolol hydrochloride (0.125 mg x kg(‐1) x min(‐1) for 1 min, followed by 0.04 mg x kg(‐1) x min(‐1) infusion)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Landiolol hydrochloride
Number of subjects: 30
Study: 17578462

Group type: EXPERIMENTAL
Intervention: NaCl 0.9%, 750 ml/m(2) body surface area (BSA)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: hydroxyethylic starch 10%, 250 ml/m(2) BSA and NaCl 0.9%, 400 ml/m(2) BSA
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: dextran 10%, 250 ml/m(2) BSA and NaCl 0.9%, 300 ml/m(2) BSA
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: hypertonic sodium chloride 7.2%/hyperoncotic hydroxyethylic starch 10%, 150 ml/m(2) BSA
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: hypertonic sodium chloride 7.2%/hyperoncotic dextran 10%, 150 ml/m(2) BSA
Number of subjects: 50
Study: 16484121

Group type: EXPERIMENTAL
Intervention: Pre‐endoscopic clinical evaluation (symptom questionnaire, H. pylori serology, hemoglobin determination)
Number of subjects: 341
Study: 12584485

Group type: EXPERIMENTAL
Intervention: Behavioral and social skill (BSS) class for children with ADHD (8-week duration)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Behavioral and social skill (BSS) class for parents of children with ADHD
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 100
Study: 10224570

Group type: EXPERIMENTAL
Intervention: Silzone coating of St. Jude Medical Masters Series mechanical heart valves
Number of subjects: 4400

Group type: COMPARATOR
Intervention: Conventional cuff of St. Jude Medical Masters Series mechanical heart valves
Number of subjects: 4400
Study: 9086315

Group type: EXPERIMENTAL
Intervention: NaCl (0.2 g/kg/day)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 2007961

Group type: EXPERIMENTAL
Intervention: 30 mmol/L alanine in WHO oral rehydration solution (ORS)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard WHO oral rehydration solution (ORS)
Number of subjects: 20
Study: 6808838

Group type: EXPERIMENTAL
Intervention: Acyclovir 3 percent ophthalmic ointment
Number of subjects: 59

Group type: COMPARATOR
Intervention: Trifluorothymidine 2 percent ointment
Number of subjects: 59
Study: 30333269

Group type: EXPERIMENTAL
Intervention: Solifenacin succinate 5 mg
Number of subjects: 126

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 126
Study: 28040502

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PAD) with toluidine blue (0.1mg/mL) and LED lamp (635nm, 200mW/cm2) for 60s
Number of subjects: 20

Group type: COMPARATOR
Intervention: Calcium hydroxide therapy (Ca(OH)2) for two weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Comparison between PAD and calcium hydroxide therapy
Number of subjects: 20
Study: 26335189

Group type: EXPERIMENTAL
Intervention: Homeopathic medication (IFC group: Influcid®) for 7 days plus standard treatment (paracetamol, ambroxol, and/or oxymetazoline)
Number of subjects: 523

Group type: COMPARATOR
Intervention: Standard treatment (ST group: paracetamol, ambroxol, and/or oxymetazoline)
Number of subjects: 523

Group type: EXPERIMENTAL
Intervention: Homeopathic medication (IFC group: Influcid®)
Number of subjects: 523

Group type: COMPARATOR
Intervention: Standard treatment (ST group)
Number of subjects: 523
Study: 23937688

Group type: EXPERIMENTAL
Intervention: Amino acid beverage deficient in dopamine precursors (phenylalanine and tyrosine)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo beverage
Number of subjects: 0
Study: 21624895

Group type: EXPERIMENTAL
Intervention: ICD patients without appropriate therapy
Number of subjects: 322

Group type: EXPERIMENTAL
Intervention: ICD patients with unused ICD
Number of subjects: 322
Study: 18972875

Group type: EXPERIMENTAL
Intervention: Test formulation of 40 mg pantoprazole
Number of subjects: 74

Group type: COMPARATOR
Intervention: Reference formulation of 40 mg pantoprazole
Number of subjects: 74
Study: 15756211

Group type: EXPERIMENTAL
Intervention: 5 ppm inhaled nitric oxide (iNO)
Number of subjects: 860

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 860
Study: 12504835

Group type: COMPARATOR
Intervention: B vitamins (folate, 10 mg; vitamin B-12, 200 microg; vitamin B-6, 20 mg/day)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: L-arginine (24 g/day)
Number of subjects: 27
Study: 10373114

Group type: EXPERIMENTAL
Intervention: Expectation of pain
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Anticipation of pain
Number of subjects: 0
Study: 8902440

Group type: EXPERIMENTAL
Intervention: Extraamniotic administration of ethacridine lactate (82 patients)
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: Intracervical prostaglandin (PG) E2 gel (100 patients)
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: Intravenous infusion of concentrated oxytocin (36 patients)
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: Vaginal misoprostol (49 patients)
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: Balloon insertion (73 patients)
Number of subjects: 340
Study: 1879977

Group type: EXPERIMENTAL
Intervention: Verapamil-SR 240 mg twice daily
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20